TOFACITINIB

148039 reported adverse events

These side effects are most commonly reported by patients taking TOFACITINIB:

# Side effect Count
0 DRUG INEFFECTIVE 37279
1 PAIN 19929
2 ARTHRALGIA 15474
3 RHEUMATOID ARTHRITIS 14977
4 CONDITION AGGRAVATED 13987
5 FATIGUE 12516
6 JOINT SWELLING 11062
7 HEADACHE 9975
8 OFF LABEL USE 9561
9 DRUG INTOLERANCE 9430
See all common reactions for TOFACITINIB

TOFACITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 69 0.9718
1 SWOLLEN JOINT COUNT INCREASED 746 0.8654
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3055 0.8488
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 137 0.7874
4 RHEUMATIC FEVER 905 0.7455
5 LUPUS VULGARIS 82 0.7069
6 RHEUMATOID FACTOR NEGATIVE 120 0.7018
7 RHEUMATOID FACTOR POSITIVE 2199 0.6762
8 DUODENAL ULCER PERFORATION 1959 0.6118
9 RED BLOOD CELL SEDIMENTATION RATE 141 0.5663
See all enriched reactions for TOFACITINIB